Senate Gene Editing Hearing: Trust In US FDA On Display

Discussion on cutting edge medical technology demonstrates the strong reputation FDA has built as a regulator. Witnesses in the gene editing field said FDA is doing a good job – and Congress is likely to leave it at that.

More from Cell & Gene Therapies

More from Advanced Technologies